Sign up
RVPH

Reviva Pharmaceuticals Holdings Inc. (NASDAQ: RVPH)

Healthcare · Biotechnology

——

Quote unavailable · The quote observation time could not be verified.

Set alert

The Quantellect read. Short interest is 3.40% of float with a 6.05% borrow fee. Six active firms cover the stock as of Nov 19, 2026; three active firms with targets average $2.67 over 12 months. Descriptive summary of the data on this page, not a recommendation.

Relative valuation—

—

Momentum—

—

Trend—

—

Short interest3.4% of float

FINRA settlement Oct 30, 2026

RVPH price chart

Price — · As of —

Open full chart →
Price details unavailable for this range.

Chart loads when this section enters view.

Text price and event history
6M plotted price range (ET)
Range6M
First date—
Last date—
Open—
High—
Low—
Close—
Volume—
Plotted bars0

Plotted OHLCV bars

No price bars are available for this range.

Event records

Event records load after the price chart.

Split-adjusted daily prices · Price as of —

Initial 6M price range summary
Range6M
First close—
Last close—
High—
Low—
Volume—
Open—
Previous close—
Day range—
52-week range
$0.30 – $14.60Through Nov 18, 2026
Volume—
Average volume (30 calendar days, 0 sessions)
—Through Nov 18, 2026
Market cap$4.59M
P/E (TTM)negative earnings —
Forward P/E—
EPS (TTM)stale vendor snapshot —
Dividend yielddata unavailable —
Beta (5-year monthly vs SPY)0.60

Price history

RVPH · nasdaq · USD

Last completed session: Nov 17, 2026

Split-adjusted · volume in shares

Missing session: Nov 18, 2026

November 2026 · 12 completed sessions
DateOpenHighLowCloseChangeVolume
0.39650.39650.300.355+0.0046+1.312785%7,488
Open 0.3965High 0.3965Low 0.30
0.34650.36310.280.3504−0.0029−0.820832%54,766
Open 0.3465High 0.3631Low 0.28
0.350.420.340.3533−0.0355−9.130658%14,484
Open 0.35High 0.42Low 0.34
0.340.40640.340.3888+0.0488+14.352941%14,519
Open 0.34High 0.4064Low 0.34
0.34850.420.33770.34−0.0353−9.405809%44,299
Open 0.3485High 0.42Low 0.3377
0.40010.4240.33050.3753+0.0317+9.225844%32,039
Open 0.4001High 0.424Low 0.3305
0.36420.41710.28720.3436−0.024−6.528836%36,514
Open 0.3642High 0.4171Low 0.2872
0.340.370.3190.3676+0.0276+8.117647%47,980
Open 0.34High 0.37Low 0.319
0.350.400.31490.34−0.04−10.526316%30,864
Open 0.35High 0.40Low 0.3149
0.3740.46590.310.38−0.021−5.236908%45,722
Open 0.374High 0.4659Low 0.31
0.41560.43350.3740.401−0.028−6.526807%19,322
Open 0.4156High 0.4335Low 0.374
0.350.4510.31230.429+0.079+22.571429%54,452
Open 0.35High 0.451Low 0.3123

Notable price movement

— · Notable price movement not available

Options flow

— · Options flow not available

Q Score

— · Q Score not available

Quantellect signals

Change since Nov 18

Insufficient data · Tide session Nov 18, 2026

Tide24Low Tide—
Squeeze34Watch—
How the scores work →

Industry comparison

— · Industry comparison not available

Upcoming events

— · Upcoming events not available

Analyst consensus

Buy

0Strong Buy
4Buy
2Neutral
0Sell
0Strong Sell

Based on 6 active firms as of Nov 19, 2026 (365-day activity window)

12-month price targets (third-party analysts)

Low$2.00
Average$2.67
High$4.00

As of Nov 19, 2026 across 3 active firms with targets. Targets are published by third-party analysts, not by Quantellect.

Full analyst forecast →

Earnings history

— · Earnings history not available

Smart-money activity

— · Smart-money activity not available

All smart-money activity →

News and press releases

All RVPH news →

Company profile

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of neuropsychiatric indications, such as schizophrenia, bipolar disorder, major depressive disorder, attention-deficit/hyperactivity

CEO
Dr. Laxminarayan Bhat Ph.D.
Headquarters
Cupertino, CA, United States
Employees
14
IPO date
Oct 18, 2018
Sector
Healthcare
Industry
Biotechnology

Data sources: exchange quotes delayed 15 minutes, FINRA short interest, SEC filings, OPRA options data and third-party analyst data. Education only. Nothing on this page is a recommendation to buy or sell a security.